Therapeutic Value Assessments of Novel Medicines in the US and Europe, 2018-2019

JAMA Netw Open. 2022 Apr 1;5(4):e226479. doi: 10.1001/jamanetworkopen.2022.6479.


This economic evaluation study assesses the clinical benefit of novel drugs approved in 2018 and 2019 and examines whether drugs approved with special regulatory designations appear to provide meaningful therapeutic value.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Drug Approval*
  • Europe
  • Humans